Blogs | Multibagger Shares

April 25, 2026

Hero Image with the Title system 1 Vs System 2 Thinking and a 2x2 Color Grid Top left Lucky gray Top right Disciplined Investor green Bottom left Confused light Gray Bottom right Bias trapped orange on a Dark Blue Background

System 1 vs System 2 Thinking: Daniel Kahneman’s Dual-Process Framework for Indian Long-Term Investors

Kahneman's dual-process theory unpacked for Indian retail investors: why System 1 hijacks portfolios, how Buffett, Munger, Klarman, and Marks engineer System 2, and how Titan Biotech's FY25 audited disclosures (₹3 Cr borrowings, 103% CFO/OP, 36.4% board independence) illustrate System-2-style management process.

April 25, 2026

Site Hero with a Dark Blue Background Large White Title dupont Three factor Decomposition of Roe and Green Subtitle Centered Multicolor Donut Chart Labeled Fy25 Reinvented

DuPont Three-Factor Decomposition of RoE: How to See Through the Most Misunderstood Ratio in Indian Investing

RoE without the DuPont decomposition is a meaningless headline. Two companies with identical 25% RoE can be a fortress compounder and a leveraged time bomb. Today's lesson teaches the framework using Titan Biotech FY25 audited numbers as a positive illustration.

April 24, 2026

Dark Blue Article Hero with Title self attribution Bias and Subtitle About Indian Investors Below is a 2x2 Color Grid Top left Gray Block Labeled lucky Top right Green Block Labeled disciplined Investor Bottom left Light Gray Block Labeled confused Bottom right Orange Block Labeled bias tapped likely bias trapped Branding multibagger Shares Appears at Top Corners

Self-Attribution Bias: Why Indian Investors Take Credit for Wins and Blame Luck for Losses

Self-attribution bias — crediting wins to skill and losses to bad luck — is the silent wealth destroyer behind 93% F&O retail losses in India. Miller & Ross (1975), Gervais & Odean (2001). Illustrative case on how Titan Biotech FY25 audited disclosures exhibit symmetric attribution at the corporate level.

April 24, 2026

Horizontal Bar Chart of Working Capital Days Cash Conversion by Fiscal Year from Fy20 to Fy25 with Values Fy20 28 Fy21 26 Fy22 22 Fy23 18 Fy24 14 Fy25 11 Fy25 Bar is Green

Working Capital Days & Cash Conversion Cycle

Decode Cash Conversion Cycle and Working Capital Days the way serious value investors do — and see how Titan Biotech's 261-day FY25 CCC is fully self-funded with near-zero debt.